Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

CollPlant Reports Technion Study Results Showing Collink.3D Provides Consistent, Tunable, And Animal-Free Alternative To Matrigel

Author: Benzinga Newsdesk | October 20, 2025 07:07am

A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D, outperformed Matrigel, a leading extracellular matrix, in supporting structured tissue formation.
The findings suggest Collink.3D could offer a consistent, tunable, and animal-free alternative for advanced tissue engineering and research applications.
Extracellular matrices are key tools in drug discovery, regenerative medicine, and tissue modeling. CollPlant's plant-based technology provides a sustainable and ethical approach without compromising performance.

Posted In: CLGN